Reduction of 64Cu-DOTATATE activity dose for somatostatin receptor PET imaging of patients with neuroendocrine neoplasms

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Standard

Reduction of 64Cu-DOTATATE activity dose for somatostatin receptor PET imaging of patients with neuroendocrine neoplasms. / Loft, M.; Carlsen, E. A.; Johnbeck, C. B.; Jensen, C.V.; Andersen, F. L.; Langer, S. W.; Otorai, P.; Knigge, U.; Kjaer, A.

In: Journal of Neuroendocrinology, Vol. 34, No. S1, 2022, p. 151-151.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Harvard

Loft, M, Carlsen, EA, Johnbeck, CB, Jensen, CV, Andersen, FL, Langer, SW, Otorai, P, Knigge, U & Kjaer, A 2022, 'Reduction of 64Cu-DOTATATE activity dose for somatostatin receptor PET imaging of patients with neuroendocrine neoplasms', Journal of Neuroendocrinology, vol. 34, no. S1, pp. 151-151. https://doi.org/10.1111/jne.13108

APA

Loft, M., Carlsen, E. A., Johnbeck, C. B., Jensen, C. V., Andersen, F. L., Langer, S. W., Otorai, P., Knigge, U., & Kjaer, A. (2022). Reduction of 64Cu-DOTATATE activity dose for somatostatin receptor PET imaging of patients with neuroendocrine neoplasms. Journal of Neuroendocrinology, 34(S1), 151-151. https://doi.org/10.1111/jne.13108

Vancouver

Loft M, Carlsen EA, Johnbeck CB, Jensen CV, Andersen FL, Langer SW et al. Reduction of 64Cu-DOTATATE activity dose for somatostatin receptor PET imaging of patients with neuroendocrine neoplasms. Journal of Neuroendocrinology. 2022;34(S1):151-151. https://doi.org/10.1111/jne.13108

Author

Loft, M. ; Carlsen, E. A. ; Johnbeck, C. B. ; Jensen, C.V. ; Andersen, F. L. ; Langer, S. W. ; Otorai, P. ; Knigge, U. ; Kjaer, A. / Reduction of 64Cu-DOTATATE activity dose for somatostatin receptor PET imaging of patients with neuroendocrine neoplasms. In: Journal of Neuroendocrinology. 2022 ; Vol. 34, No. S1. pp. 151-151.

Bibtex

@article{35c8f54fbfc94220b5790975a98994d6,
title = "Reduction of 64Cu-DOTATATE activity dose for somatostatin receptor PET imaging of patients with neuroendocrine neoplasms",
keywords = "64cu-dotatate, neuroendocrine neoplasm, pet imaging, ssr imaging",
author = "M. Loft and Carlsen, {E. A.} and Johnbeck, {C. B.} and C.V. Jensen and Andersen, {F. L.} and Langer, {S. W.} and P. Otorai and U. Knigge and A. Kjaer",
year = "2022",
doi = "10.1111/jne.13108",
language = "English",
volume = "34",
pages = "151--151",
journal = "Journal of Neuroendocrinology",
issn = "0953-8194",
publisher = "Wiley-Blackwell",
number = "S1",

}

RIS

TY - ABST

T1 - Reduction of 64Cu-DOTATATE activity dose for somatostatin receptor PET imaging of patients with neuroendocrine neoplasms

AU - Loft, M.

AU - Carlsen, E. A.

AU - Johnbeck, C. B.

AU - Jensen, C.V.

AU - Andersen, F. L.

AU - Langer, S. W.

AU - Otorai, P.

AU - Knigge, U.

AU - Kjaer, A.

PY - 2022

Y1 - 2022

KW - 64cu-dotatate

KW - neuroendocrine neoplasm

KW - pet imaging

KW - ssr imaging

U2 - 10.1111/jne.13108

DO - 10.1111/jne.13108

M3 - Conference abstract in journal

C2 - 35253281

VL - 34

SP - 151

EP - 151

JO - Journal of Neuroendocrinology

JF - Journal of Neuroendocrinology

SN - 0953-8194

IS - S1

ER -

ID: 335374085